Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC HDAC6-IN-13 | 2837128-41-1 | C23H22N4O | 50 MG
SDP

Catalog No. 5000375893
Encompass_Preferred

HDAC6-IN-13 (Compound 35m) is a potent, highly selective, orally active HDAC6 inhibitor with an IC50 of 0.019 μM. It also inhibits HDAC1, HDAC2, and HDAC3 with IC50s of 1.53, 2.06, and 1.03 μM, respectively. This compound demonstrates significant BBB permeability and anti-inflammatory activity.

  • Potent and highly selective HDAC6 inhibitor.
  • Exhibits significant blood-brain barrier permeability.
  • Demonstrates anti-inflammatory activity.
  • Slow-on and slow-off tight-binding HDAC6 inhibitor.
  • High oral bioavailability (F% = 93.4%) in mice.
  • Inhibits LPS-induced inflammation in mice.

Catalog No. 50-003-75893 Supplier Medchemexpress LLC Supplier No. HY15126150MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

HDAC6-IN-13 (Compound 35m) is a potent, highly selective, orally active HDAC6 inhibitor with an IC50 of 0.019 μM. It also inhibits HDAC1, HDAC2, and HDAC3 with IC50s of 1.53, 2.06, and 1.03 μM, respectively. This compound demonstrates significant BBB permeability and anti-inflammatory activity.

  • Potent and highly selective HDAC6 inhibitor.
  • Exhibits significant blood-brain barrier permeability.
  • Demonstrates anti-inflammatory activity.
  • Slow-on and slow-off tight-binding HDAC6 inhibitor.
  • High oral bioavailability (F% = 93.4%) in mice.
  • Inhibits LPS-induced inflammation in mice.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.